No label defined (Q38638782)

5 September 2017

title

Enhanced protection against experimental Junin virus infection through the use of a modified favipiravir loading dose strategy (English)

1 reference

5 September 2017

1 reference

Brian B Gowen

1

1 reference

5 September 2017

Jonna B Westover

2

1 reference

5 September 2017

Eric J Sefing

3

1 reference

5 September 2017

Arnaud J Van Wettere

4

1 reference

5 September 2017

Kevin W Bailey

5

1 reference

5 September 2017

Luci Wandersee

6

1 reference

5 September 2017

Takashi Komeno

7

1 reference

5 September 2017

Yousuke Furuta

8

1 reference

5 September 2017

publication date

2 August 2017

1 reference

5 September 2017

1 reference

5 September 2017

volume

145

1 reference

5 September 2017

page(s)

131-135

1 reference

Monoclonal antibody therapy for Junin virus infection

5 September 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Experimental Treatment with Favipiravir for Ebola Virus Disease (the JIKI Trial): A Historically Controlled, Single-Arm Proof-of-Concept Trial in Guinea

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Low-dose ribavirin potentiates the antiviral activity of favipiravir against hemorrhagic fever viruses

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Favipiravir (T-705) inhibits Junín virus infection and reduces mortality in a guinea pig model of Argentine hemorrhagic fever

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Favipiravir (T-705), a novel viral RNA polymerase inhibitor

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Effective Oral Favipiravir (T-705) Therapy Initiated after the Onset of Clinical Disease in a Model of Arenavirus Hemorrhagic Fever

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Junín virus. A XXI century update

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

T-705 (favipiravir) inhibition of arenavirus replication in cell culture

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Chapare virus, a newly discovered arenavirus isolated from a fatal hemorrhagic fever case in Bolivia

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Treatment of Argentine hemorrhagic fever

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Dose translation from animal to human studies revisited

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

In Vitro and In Vivo Activities of T-705 against Arenavirus and Bunyavirus Infections

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

Prevalence of infection with Junin virus in rodent populations in the epidemic area of Argentine hemorrhagic fever.

31 August 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5580092

10.1016/J.ANTIVIRAL.2017.07.019

31 August 2018

Identifiers

DOI

1 reference

5 September 2017

0 references

1 reference